Mankind Pharma Q3 Results FY26: PAT rises 7.5% to Rs 408 crore | Check revenue and other earning DETAILS

Mankind Pharma on Tuesday reported a steady performance in the December quarter (Q3 FY2026), with net profit rising 7.5 per cent year-on-year to Rs 408.7 crore, while revenue increased 11.5 per cent to Rs 3,567 crore. EBITDA grew 12.7 per cent to Rs 919.6 crore, and EBITDA margins improved slightly to 25.8 per cent from 25.5 per cent in the year-ago period."We remain confident of delivering long-term sustainable growth anchored by four key pillars -- steady base business, fast-growing specialty chronic, high potential OTC business, and super specialty BSV portfolio," Vice Chairman & Managing Director Rajeev Juneja stated.The company's revenue in the domestic market stood at Rs 3,046 crore during the third quarter of the current fiscal year, up 11 per cent from Rs 2,742 crore in the year-ago period.Mankind Pharma share priceShares of Mankind Pharma closed at Rs 2155.90 per share on Tuesday, February 3 -- which is 4.30 per cent above the previous close of Rs 2067.10 apiece. During the day, the counter swung between Rs 2189.75 and Rs 2111.45 per share.The 52-week high for the company's share came on 15/07/2025 at Rs 2,726.75 per share; while 52-week low came in at Rs 2,050 on 02/02/2026. According to BSE website, "the scrip PE is greater than 50 for previous 4 trailing quarters."The shares of the company are up 2.94 per cent in a week and 1.51 per cent in 2 weeks. However, it declined 2.12 per cent in a month, 0.33 per cent in year to date, 10.24 per cent in 3 months, 15.86 per cent in 6 months, 16.56 per cent in a year and 5.83 per cent in 2 years.Notably, Mankind Pharma is a constituent of BSE 200 index and enjoys a market capitalisation of Rs 88,996.65 crore.Stock MarketIn one of the biggest single-day gains after India and the US announced a long-awaited trade deal, easing tariff-related concerns that have weighed on Indian markets for months, the stock market benchmark index Sensex zoomed 2,072 points while the broader Nifty closed above the 25,700 level on Tuesday, February 3.India and the US agreed to a trade deal under which Washington will bring down the reciprocal tariff on Indian goods to 18 per cent from the current 25 per cent, US President Donald Trump said on Monday after a phone conversation with Prime Minister Narendra Modi.(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money-related decisions.)